Kasugamycin (hydrochloride) |
An aminoglycoside with diverse biological activities; active against S. dy… |
100 mg |
15322-100 |
More Info
|
Katacalcin (trifluoroacetate salt) |
An endogenous peptide; expressed in, and secreted from, thyroid parafollic… |
1 mg |
39285-1 |
More Info
|
Katacalcin (trifluoroacetate salt) |
An endogenous peptide; expressed in, and secreted from, thyroid parafollic… |
10 mg |
39285-10 |
More Info
|
Katacalcin (trifluoroacetate salt) |
An endogenous peptide; expressed in, and secreted from, thyroid parafollic… |
25 mg |
39285-25 |
More Info
|
Katacalcin (trifluoroacetate salt) |
An endogenous peptide; expressed in, and secreted from, thyroid parafollic… |
5 mg |
39285-5 |
More Info
|
KAT8 Inhibitor 19 |
A KAT8 inhibitor; selective for KAT8 over KAT2A, KAT2B, KAT3B, KAT6A, and… |
1 mg |
38977-1 |
More Info
|
KAT8 Inhibitor 19 |
A KAT8 inhibitor; selective for KAT8 over KAT2A, KAT2B, KAT3B, KAT6A, and… |
10 mg |
38977-10 |
More Info
|
KAT8 Inhibitor 19 |
A KAT8 inhibitor; selective for KAT8 over KAT2A, KAT2B, KAT3B, KAT6A, and… |
25 mg |
38977-25 |
More Info
|
KAT8 Inhibitor 19 |
A KAT8 inhibitor; selective for KAT8 over KAT2A, KAT2B, KAT3B, KAT6A, and… |
5 mg |
38977-5 |
More Info
|
Kaurenoic Acid |
A diterpene with diverse biological activities; cytotoxic to a variety of… |
1 mg |
28957-1 |
More Info
|
Kaurenoic Acid |
A diterpene with diverse biological activities; cytotoxic to a variety of… |
10 mg |
28957-10 |
More Info
|
Kaurenoic Acid |
A diterpene with diverse biological activities; cytotoxic to a variety of… |
25 mg |
28957-25 |
More Info
|
Kaurenoic Acid |
A diterpene with diverse biological activities; cytotoxic to a variety of… |
5 mg |
28957-5 |
More Info
|
Kavain |
An analytical reference standard categorized as a kavalactone; has analges… |
1 mg |
33881-1 |
More Info
|
Kavain |
An analytical reference standard categorized as a kavalactone; has analges… |
5 mg |
33881-5 |
More Info
|
Kavain |
A kavalactone with diverse biological activities; a positive allosteric mo… |
10 mg |
26524-10 |
More Info
|
Kavain |
A kavalactone with diverse biological activities; a positive allosteric mo… |
100 mg |
26524-100 |
More Info
|
Kavain |
A kavalactone with diverse biological activities; a positive allosteric mo… |
50 mg |
26524-50 |
More Info
|
Kazusamycin A |
An antitumor antibiotic that inhibits nuclear export and translocation of… |
100 µg |
20137-100 |
More Info
|
Kazusamycin A |
An antitumor antibiotic that inhibits nuclear export and translocation of… |
500 µg |
20137-500 |
More Info
|
Kazusamycin B |
A bacterial metabolite; has antifungal activity against S. pombe and R. ja… |
100 µg |
28119-100 |
More Info
|
Kazusamycin B |
A bacterial metabolite; has antifungal activity against S. pombe and R. ja… |
500 µg |
28119-500 |
More Info
|
K252b |
A cell-impermeable kinase inhibitor, first described as an inhibitor of PK… |
1 mg |
11339-1 |
More Info
|
K252b |
A cell-impermeable kinase inhibitor, first described as an inhibitor of PK… |
500 µg |
11339-500 |
More Info
|
KB-130015 |
An antiarrhythmic agent; inhibits acetylcholine or adenosine-induced potas… |
1 mg |
33461-1 |
More Info
|
KB-130015 |
An antiarrhythmic agent; inhibits acetylcholine or adenosine-induced potas… |
10 mg |
33461-10 |
More Info
|
KB-130015 |
An antiarrhythmic agent; inhibits acetylcholine or adenosine-induced potas… |
25 mg |
33461-25 |
More Info
|
KB-130015 |
An antiarrhythmic agent; inhibits acetylcholine or adenosine-induced potas… |
5 mg |
33461-5 |
More Info
|
KB2115 |
A synthetic thyroid hormone mimetic that lowers total and LDL cholesterol… |
100 mg |
10011054-100 |
More Info
|
KB2115 |
A synthetic thyroid hormone mimetic that lowers total and LDL cholesterol… |
25 mg |
10011054-25 |
More Info
|
KB2115 |
A synthetic thyroid hormone mimetic that lowers total and LDL cholesterol… |
5 mg |
10011054-5 |
More Info
|
KB2115 |
A synthetic thyroid hormone mimetic that lowers total and LDL cholesterol… |
50 mg |
10011054-50 |
More Info
|
KB-0742 (hydrochloride) |
A Cdk9 inhibitor (IC50 = 6 nM); selective for Cdk9 over Cdk1-8 (IC50s = 39… |
10 mg |
39772-10 |
More Info
|
KB-0742 (hydrochloride) |
A Cdk9 inhibitor (IC50 = 6 nM); selective for Cdk9 over Cdk1-8 (IC50s = 39… |
25 mg |
39772-25 |
More Info
|
KB-0742 (hydrochloride) |
A Cdk9 inhibitor (IC50 = 6 nM); selective for Cdk9 over Cdk1-8 (IC50s = 39… |
5 mg |
39772-5 |
More Info
|
KB-0742 (hydrochloride) |
A Cdk9 inhibitor (IC50 = 6 nM); selective for Cdk9 over Cdk1-8 (IC50s = 39… |
50 mg |
39772-50 |
More Info
|
K-Biotin-W-Histone H2B (108-125) (trifluoroacetate salt) |
A biotinylated peptide fragment of histone H2B |
1 mg |
28214-1 |
More Info
|
kb NB 142-70 |
A selective PKD inhibitor (IC50s = 28.3, 58.7, and 53.2 nM for PKD1, 2, an… |
10 mg |
18002-10 |
More Info
|
kb NB 142-70 |
A selective PKD inhibitor (IC50s = 28.3, 58.7, and 53.2 nM for PKD1, 2, an… |
25 mg |
18002-25 |
More Info
|
kb NB 142-70 |
A selective PKD inhibitor (IC50s = 28.3, 58.7, and 53.2 nM for PKD1, 2, an… |
5 mg |
18002-5 |
More Info
|
kb NB 142-70 |
A selective PKD inhibitor (IC50s = 28.3, 58.7, and 53.2 nM for PKD1, 2, an… |
50 mg |
18002-50 |
More Info
|
kb-NB77-78 |
An inactive analog of the PKD inhibitor CID755673; does not bind PKD1 in a… |
1 mg |
21562-1 |
More Info
|
kb-NB77-78 |
An inactive analog of the PKD inhibitor CID755673; does not bind PKD1 in a… |
10 mg |
21562-10 |
More Info
|
kb-NB77-78 |
An inactive analog of the PKD inhibitor CID755673; does not bind PKD1 in a… |
25 mg |
21562-25 |
More Info
|
kb-NB77-78 |
An inactive analog of the PKD inhibitor CID755673; does not bind PKD1 in a… |
5 mg |
21562-5 |
More Info
|
KB-R7943 (mesylate) |
A selective inhibitor of the reverse mode of NCX1 (IC50 = 1.2-2.4 µM… |
10 mg |
16352-10 |
More Info
|
KB-R7943 (mesylate) |
A selective inhibitor of the reverse mode of NCX1 (IC50 = 1.2-2.4 µM… |
5 mg |
16352-5 |
More Info
|
KB-R7943 (mesylate) |
A selective inhibitor of the reverse mode of NCX1 (IC50 = 1.2-2.4 µM… |
50 mg |
16352-50 |
More Info
|
K252c |
A cell-permeable PKC inhibitor (IC50s = 2.45 and 25.7 µM for PKC and… |
1 mg |
13514-1 |
More Info
|
K252c |
A cell-permeable PKC inhibitor (IC50s = 2.45 and 25.7 µM for PKC and… |
10 mg |
13514-10 |
More Info
|
K252c |
A cell-permeable PKC inhibitor (IC50s = 2.45 and 25.7 µM for PKC and… |
5 mg |
13514-5 |
More Info
|
KC01 |
A covalent inhibitor of ABHD16A (IC50s = 90 and 520 nM for human and mouse… |
1 mg |
17364-1 |
More Info
|
KC01 |
A covalent inhibitor of ABHD16A (IC50s = 90 and 520 nM for human and mouse… |
500 µg |
17364-500 |
More Info
|
KC02 |
An inactive control probe (IC50 > 10 µM) for KC01 (Item No. 17364),… |
1 mg |
17365-1 |
More Info
|
KC02 |
An inactive control probe (IC50 > 10 µM) for KC01 (Item No. 17364),… |
100 µg |
17365-100 |
More Info
|
KC02 |
An inactive control probe (IC50 > 10 µM) for KC01 (Item No. 17364),… |
500 µg |
17365-500 |
More Info
|
KC7F2 |
An inhibitor of HIF-1α protein translation; suppresses phosphorylati… |
10 mg |
14123-10 |
More Info
|
KC7F2 |
An inhibitor of HIF-1α protein translation; suppresses phosphorylati… |
5 mg |
14123-5 |
More Info
|
KC7F2 |
An inhibitor of HIF-1α protein translation; suppresses phosphorylati… |
50 mg |
14123-50 |
More Info
|
K252d |
An indolocarbazole alkaloid found in Nocardiopsis; a PKC inhibitor; inhibi… |
1 mg |
28469-1 |
More Info
|
KD 025 |
A ROCK2 inhibitor (IC50 = 0.105 µM); selective for ROCK2 over ROCK1… |
10 mg |
17055-10 |
More Info
|
KD 025 |
A ROCK2 inhibitor (IC50 = 0.105 µM); selective for ROCK2 over ROCK1… |
100 mg |
17055-100 |
More Info
|
KD 025 |
A ROCK2 inhibitor (IC50 = 0.105 µM); selective for ROCK2 over ROCK1… |
25 mg |
17055-25 |
More Info
|
KD 025 |
A ROCK2 inhibitor (IC50 = 0.105 µM); selective for ROCK2 over ROCK1… |
50 mg |
17055-50 |
More Info
|
KD 5170 |
A mercaptoketone-based inhibitor of class I and II HDACs (IC50s = 20, 2,06… |
1 mg |
13214-1 |
More Info
|
KD 5170 |
A mercaptoketone-based inhibitor of class I and II HDACs (IC50s = 20, 2,06… |
10 mg |
13214-10 |
More Info
|
KD 5170 |
A mercaptoketone-based inhibitor of class I and II HDACs (IC50s = 20, 2,06… |
25 mg |
13214-25 |
More Info
|
KD 5170 |
A mercaptoketone-based inhibitor of class I and II HDACs (IC50s = 20, 2,06… |
5 mg |
13214-5 |
More Info
|
KDdiA-PC |
Oxidized LDL (oxLDL) particles contain low molecular weight species which… |
1 mg |
62935-1 |
More Info
|
KDdiA-PC |
Oxidized LDL (oxLDL) particles contain low molecular weight species which… |
10 mg |
62935-10 |
More Info
|
KDdiA-PC |
Oxidized LDL (oxLDL) particles contain low molecular weight species which… |
5 mg |
62935-5 |
More Info
|
KDdiA-PC |
Oxidized LDL (oxLDL) particles contain low molecular weight species which… |
500 µg |
62935-500 |
More Info
|
KDM5-C70 |
An inhibitor of JARID1B (IC50 = 49 nM); selective for JARID1B over KDM4C (… |
10 mg |
36817-10 |
More Info
|
KDM5-C70 |
An inhibitor of JARID1B (IC50 = 49 nM); selective for JARID1B over KDM4C (… |
25 mg |
36817-25 |
More Info
|
KDM5-C70 |
An inhibitor of JARID1B (IC50 = 49 nM); selective for JARID1B over KDM4C (… |
5 mg |
36817-5 |
More Info
|
KDM5-C70 |
An inhibitor of JARID1B (IC50 = 49 nM); selective for JARID1B over KDM4C (… |
50 mg |
36817-50 |
More Info
|
KDM4D-IN-1 |
An inhibitor of JMJD2D (IC50 = 0.41 µM); selective for JMJD2D over J… |
1 mg |
37431-1 |
More Info
|
KDM4D-IN-1 |
An inhibitor of JMJD2D (IC50 = 0.41 µM); selective for JMJD2D over J… |
10 mg |
37431-10 |
More Info
|
KDM4D-IN-1 |
An inhibitor of JMJD2D (IC50 = 0.41 µM); selective for JMJD2D over J… |
25 mg |
37431-25 |
More Info
|
KDM4D-IN-1 |
An inhibitor of JMJD2D (IC50 = 0.41 µM); selective for JMJD2D over J… |
5 mg |
37431-5 |
More Info
|
Kdo2-Lipid A (sodium salt) |
The active component of LPS; selectively induces Il-6 expression in wild-t… |
1 mg |
10860-1 |
More Info
|
KDU691 |
An antimalarial compound; inhibits the activity of recombinant P. vivax PI… |
1 mg |
29019-1 |
More Info
|
KDU691 |
An antimalarial compound; inhibits the activity of recombinant P. vivax PI… |
10 mg |
29019-10 |
More Info
|
KDU691 |
An antimalarial compound; inhibits the activity of recombinant P. vivax PI… |
25 mg |
29019-25 |
More Info
|
KDU691 |
An antimalarial compound; inhibits the activity of recombinant P. vivax PI… |
5 mg |
29019-5 |
More Info
|
Keap1 (human, recombinant) |
Source: Recombinant human N-terminal His-GST-tagged Keap1 expressed in ins… |
100 µg |
32035-100 |
More Info
|
KEMPFPKYPVEP Peptide (bovine, ovine) (trifluoroacetate salt) |
A peptide fragment of β-casein; can be produced by the protease M fro… |
10 mg |
38850-10 |
More Info
|
KEMPFPKYPVEP Peptide (bovine, ovine) (trifluoroacetate salt) |
A peptide fragment of β-casein; can be produced by the protease M fro… |
100 mg |
38850-100 |
More Info
|
KEMPFPKYPVEP Peptide (bovine, ovine) (trifluoroacetate salt) |
A peptide fragment of β-casein; can be produced by the protease M fro… |
250 mg |
38850-250 |
More Info
|
KEMPFPKYPVEP Peptide (bovine, ovine) (trifluoroacetate salt) |
A peptide fragment of β-casein; can be produced by the protease M fro… |
50 mg |
38850-50 |
More Info
|
Kemptide |
A synthetic heptapeptide that acts as a specific substrate for PKA |
1 mg |
15555-1 |
More Info
|
Kemptide |
A synthetic heptapeptide that acts as a specific substrate for PKA |
10 mg |
15555-10 |
More Info
|
Kemptide |
A synthetic heptapeptide that acts as a specific substrate for PKA |
25 mg |
15555-25 |
More Info
|
Kemptide |
A synthetic heptapeptide that acts as a specific substrate for PKA |
5 mg |
15555-5 |
More Info
|
Kendomycin |
A macrolide from Streptomyces which displays potent cytotoxicity against s… |
100 µg |
11037-100 |
More Info
|
Kendomycin |
A macrolide from Streptomyces which displays potent cytotoxicity against s… |
500 µg |
11037-500 |
More Info
|
Kenpaullone |
An ATP-competitive inhibitor of several CDKs as well as GSK3β |
1 mg |
10010239-1 |
More Info
|
Kenpaullone |
An ATP-competitive inhibitor of several CDKs as well as GSK3β |
10 mg |
10010239-10 |
More Info
|
Kenpaullone |
An ATP-competitive inhibitor of several CDKs as well as GSK3β |
25 mg |
10010239-25 |
More Info
|
Kenpaullone |
An ATP-competitive inhibitor of several CDKs as well as GSK3β |
5 mg |
10010239-5 |
More Info
|